Applications of nanobodies
S Muyldermans - Annual review of animal biosciences, 2021 - annualreviews.org
Unique, functional, homodimeric heavy chain–only antibodies, devoid of light chains, are
circulating in the blood of Camelidae. These antibodies recognize their cognate antigen via …
circulating in the blood of Camelidae. These antibodies recognize their cognate antigen via …
ImmunoPET: concept, design, and applications
W Wei, ZT Rosenkrans, J Liu, G Huang, QY Luo… - Chemical …, 2020 - ACS Publications
Immuno-positron emission tomography (immunoPET) is a paradigm-shifting molecular
imaging modality combining the superior targeting specificity of monoclonal antibody (mAb) …
imaging modality combining the superior targeting specificity of monoclonal antibody (mAb) …
Bridging bio–nano science and cancer nanomedicine
M Bjornmalm, KJ Thurecht, M Michael, AM Scott… - ACS …, 2017 - ACS Publications
The interface of bio–nano science and cancer medicine is an area experiencing much
progress but also beset with controversy. Core concepts of the field eg, the enhanced …
progress but also beset with controversy. Core concepts of the field eg, the enhanced …
Nanobodies as therapeutics: big opportunities for small antibodies
S Steeland, RE Vandenbroucke, C Libert - Drug discovery today, 2016 - Elsevier
Highlights•Nanobodies (Nbs) are camelid-derived single-domain antibodies.•Nbs have
powerful binding and inhibitory capacity with great therapeutic potential.•Nbs are used in …
powerful binding and inhibitory capacity with great therapeutic potential.•Nbs are used in …
Nanobodies: natural single-domain antibodies
S Muyldermans - Annual review of biochemistry, 2013 - annualreviews.org
Sera of camelids contain both conventional heterotetrameric antibodies and unique
functional heavy (H)-chain antibodies (HCAbs). The H chain of these homodimeric …
functional heavy (H)-chain antibodies (HCAbs). The H chain of these homodimeric …
Nanobody: a promising toolkit for molecular imaging and disease therapy
G Bao, M Tang, J Zhao, X Zhu - EJNMMI research, 2021 - Springer
Nanobodies are the recombinant variable domains of heavy-chain-only antibodies, with
many unique properties such as small size, excellent solubility, superior stability, quick …
many unique properties such as small size, excellent solubility, superior stability, quick …
Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding
KN Iskander, MF Osuchowski… - Physiological …, 2013 - journals.physiology.org
Sepsis represents the host's systemic inflammatory response to a severe infection. It causes
substantial human morbidity resulting in hundreds of thousands of deaths each year …
substantial human morbidity resulting in hundreds of thousands of deaths each year …
Ultrasmall inorganic nanoparticles: State-of-the-art and perspectives for biomedical applications
K Zarschler, L Rocks, N Licciardello, L Boselli… - … , Biology and Medicine, 2016 - Elsevier
Ultrasmall nanoparticulate materials with core sizes in the 1-3 nm range bridge the gap
between single molecules and classical, larger-sized nanomaterials, not only in terms of …
between single molecules and classical, larger-sized nanomaterials, not only in terms of …
Camelid single-domain antibodies: historical perspective and future outlook
M Arbabi-Ghahroudi - Frontiers in immunology, 2017 - frontiersin.org
Tremendous effort has been expended over the past two and a half decades to understand
many aspects of camelid heavy chain antibodies, from their biology, evolution, and …
many aspects of camelid heavy chain antibodies, from their biology, evolution, and …
Phase I study of 68Ga-HER2-nanobody for PET/CT assessment of HER2 expression in breast carcinoma
Human epidermal growth factor receptor 2 (HER2) status is one of the major tumor
characteristics in breast cancer to guide therapy. Anti-HER2 treatment has clear survival …
characteristics in breast cancer to guide therapy. Anti-HER2 treatment has clear survival …